Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC beta-lactamase in Brazil

J Med Microbiol. 2008 Dec;57(Pt 12):1590-1592. doi: 10.1099/jmm.0.2008/002774-0.

Authors

Mónica Pavez¹, Patrícia Neves¹, Milena Dropa², Maria H Matté², Renato S Grinbaum³, Maria R Elmor de Araújo³, Elsa M Mamizuka¹, Nilton Lincopan¹

Affiliations

¹ Laboratory of Clinical Microbiology, School of Pharmacy, University of São Paulo, CP 66083, São Paulo, SP, Brazil.
² School of Public Health, University of São Paulo, Avenida Doutor Arnaldo 715, São Paulo, SP, Brazil.
³ Laboratory of Clinical Microbiology and Infectious Diseases Team, Hospital Beneficiência Portuguesa, São Paulo, Brazil.

PMID: 19018036
DOI: 10.1099/jmm.0.2008/002774-0

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology
Bacteremia / microbiology*
Brazil
Carbapenems / pharmacology*
Drug Resistance, Multiple, Bacterial
Escherichia coli / drug effects*
Escherichia coli / enzymology
Escherichia coli / isolation & purification
Escherichia coli Infections / microbiology*
Fatal Outcome
Humans
Male
Microbial Sensitivity Tests
Middle Aged
beta-Lactam Resistance*
beta-Lactamases / biosynthesis*

Substances

Anti-Bacterial Agents
Carbapenems
beta-lactamase CMY-2
beta-Lactamases